Ahn-Gook Pharmaceutical Co. Ltd (001540) — Cash Flow Quality Index
Ahn-Gook Pharmaceutical Co. Ltd (001540) has a Cash Flow Quality Index of 4.29x as of September 2025. Operating cash flow of ₩14.44 Billion exceeds net income of ₩3.37 Billion, indicating high earnings quality where cash backs reported profits. Explore 001540 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Ahn-Gook Pharmaceutical Co. Ltd Cash Flow Quality Index (2012–2024)
Historical Cash Flow Quality Index for Ahn-Gook Pharmaceutical Co. Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 001540 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Ahn-Gook Pharmaceutical Co. Ltd (2012–2024)
Year-by-year earnings quality comparison for Ahn-Gook Pharmaceutical Co. Ltd. For live market cap and the full company financial profile, see Ahn-Gook Pharmaceutical Co. Ltd (001540) market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.30x | ₩4.91 Billion | ₩16.34 Billion | ▲ +122.6% |
| 2023 | -1.33x | ₩-1.33 Billion | ₩998.28 Million | ▼ -611.3% |
| 2022 | 0.26x | ₩1.79 Billion | ₩6.88 Billion | ▼ -30.4% |
| 2021 | 0.37x | ₩1.47 Billion | ₩3.94 Billion | ▼ -95.7% |
| 2019 | 8.71x | ₩22.08 Billion | ₩2.54 Billion | ▲ +9683.0% |
| 2018 | -0.09x | ₩-1.20 Billion | ₩13.22 Billion | ▼ -104.2% |
| 2017 | 2.14x | ₩17.46 Billion | ₩8.16 Billion | ▼ -77.4% |
| 2016 | 9.47x | ₩12.62 Billion | ₩1.33 Billion | ▲ +341.0% |
| 2015 | 2.15x | ₩19.11 Billion | ₩8.90 Billion | ▲ +284.7% |
| 2013 | 0.56x | ₩3.64 Billion | ₩6.52 Billion | ▼ -82.4% |
| 2012 | 3.18x | ₩11.51 Billion | ₩3.63 Billion | — |